for the Period Ended 31 March 2025
Directors report | |
Profit and loss | |
Balance sheet | |
Additional notes | |
Balance sheet notes | |
Community Interest Report |
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 31 March 2025
Principal activities of the company
Directors
The director shown below has held office during the whole of the period from
1 April 2024
to
31 March 2025
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Director
for the Period Ended
2025 | 2024 | |
---|---|---|
|
£ |
£ |
Administrative expenses: |
(
|
(
|
Operating profit(or loss): |
( |
( |
Profit(or loss) before tax: |
( |
( |
Profit(or loss) for the financial year: |
( |
( |
As at
Notes | 2025 | 2024 | |
---|---|---|---|
|
£ |
£ |
|
Creditors: amounts falling due within one year: | 3 |
(
|
(
|
Net current assets (liabilities): |
( |
( |
|
Total assets less current liabilities: |
( |
( |
|
Total net assets (liabilities): |
( |
( |
|
Members' funds | |||
Profit and loss account: |
( |
( |
|
Total members' funds: |
( |
( |
The notes form part of these financial statements
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 31 March 2025
Basis of measurement and preparation
Turnover policy
Other accounting policies
for the Period Ended 31 March 2025
2025 | 2024 | |
---|---|---|
Average number of employees during the period |
|
|
for the Period Ended 31 March 2025
2025 | 2024 | |
---|---|---|
£ | £ | |
Other creditors |
|
|
Total |
|
|
The company has not begin trading during the financial year in question. The companies activities have been restricted to research.
The company’s stakeholders include the Directors of the company, who have been brought up to date with the companies’ activities at company meetings. The company has appointed a Care Manager to conduct research and participate in the management and strategic direction of the company. Feedback has been exchanged at the company’s meetings between the Care Manager and Company’s Directors.
No remuneration was received
No transfer of assets other than for full consideration
This report was approved by the board of directors on
24 April 2025
And signed on behalf of the board by:
Name: Sammuel KITONE
Status: Director